Skip to main content Olivia Niland Olivia Niland Published Jun 11, 2026 Some employers are planning to eliminate coverage for GLP-1 weight-loss drugs in 2027 as usage rises, counteracting savings from reduced prices
Personalized and carefully monitored to support your goals
And critically, the scientific evidence, or lack thereof, supporting this increasingly popular treatment
The gestational diabetes and hypertensive disorders of pregnancy composites as well as gestational hypertension continued to be significantly decreased even at prescriptions within 6 and 3 months of pregnancy, the researchers wrote
If you are self-administering your Semaglutide at home, we will ensure you are fully trained in the process
It is: This matters because safety begins in formulation and manufacturing